This randomized clinical trial study was aimed to evaluate the efficacy and safety of Novosis-Inject (β-TCP + hydrogel + BMP-2) (CGBio Co., Inc., Korea) (Gr 1: n = 43) for socket preservation, compared to ExcelOs Inject (β-TCP + hydrogel) (Gr 2: n = 45). The results showed that the alveolar bone resorptions in height and width at 3 different levels were significantly  lower in Gr 1 than Gr 2 (all, p < 0.001).

Clinical Evaluation of Efficacy and Safety of Novosis-Inject Containing BMP-2 for Socket Preservation after Extraction of a Single-rooted Tooth